ARCHIVES

Continous Hormone Therapy Superior To Intermittent In 17-Year SWOG Study

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

New Breast Cancer Trials to Include Pre Vs. Post Operative Chemotherapy, CSF Pilot Studies

August 5, 1988

Mesothelioma Survival, QOL Improved With Alimta, Platinol

March 28, 2003

NCI Branch Chiefs, ACCI Join Support For DeVita

June 25, 1981

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

January 17, 1992

NIH Cool On OIG, But the Awardees Love it, DeVita Says

October 17, 1986

Hatfield, Kennedy Bill would Establish Panel for Clinical Research

February 16, 1996